Aβ₄₀ Improves Cerebrovascular Endothelial Function via NOX4-Dependent Hydrogen Peroxide Release.

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Alzheimer's disease (AD) is linked to amyloid beta (Aβ) accumulation, causing cognitive decline and cerebrovascular issues.
• Reactive oxygen species (ROS), especially from NADPH oxidase 2 (NOX2), worsen vascular dysfunction and Aβ deposition in AD.
• The specific role of the NOX4 isoform in AD pathogenesis requires further investigation.

Purpose of the Study:

• To investigate the role of the NOX4 isoform in Alzheimer's disease pathogenesis.
• To determine if NOX4 mediates the effects of Aβ40 on brain endothelial cells.

Main Methods:

• Predominant expression of NOX4 was identified in bEnd.3 mouse brain endothelial cells.
• Cells were treated with Aβ40, and hydrogen peroxide (H2O2) and nitric oxide (NO) release were measured.
• Pharmacological inhibitors targeting NOX isoforms were used to assess NOX4 involvement in Aβ40-induced H2O2 production.

Main Results:

• Aβ40 treatment significantly increased H2O2 and NO release, enhancing endothelial cell viability.
• Aβ40-induced H2O2 production was reduced by pan-NOX and NOX1/4-selective inhibitors.
• Given NOX4's exclusive expression in bEnd.3 cells, these findings confirm NOX4's role in Aβ40-stimulated H2O2 release.

Conclusions:

• The study demonstrates that Aβ40 peptide exerts beneficial effects on bEnd.3 endothelial cells.
• These beneficial effects are mediated through a NOX4-dependent mechanism.
• NOX4 plays a significant role in the cellular response to Aβ40 in the context of Alzheimer's disease research.